MedPath

Public Title:A Study on the Registration of The Use of Feilike HeJi in Adults

Conditions
Bronchial Asthma
Interventions
Other: NO.
Registration Number
NCT04714489
Lead Sponsor
China Academy of Chinese Medical Sciences
Brief Summary

Feilike HeJi is produced by Guizhou Jianxing Pharmaceutical Co. LTD. For the treatment of phlegm heat caused by lung cough phlegm yellow, bronchial asthma, bronchitis, see the syndrome of proprietary Chinese medicine (approval number: Z20025136) approved by the state and the drug from radix scutellariae, radix peucedani, radix stemonae, red gentian root of deal, phoenix tree, spreading hedyotis herb, red tube 7 flavour, with qingrejiedu, antitussive expectorant effect. In order to fully understand the safety of Feilike HeJi in clinical practice and fulfill the responsibility of production enterprises for patients, the production enterprises initiated this study to further evaluate the safety and understanding of the function characteristics of Feilike HeJi in a wide range of people, so as to guide the clinical rational drug use.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3000
Inclusion Criteria
  • All adult patients (age ≥18 years old) who use Feilike HeJi at the specified monitoring time and in the monitoring center (department) ;
  • Must voluntarily participate in this study;
  • Must meet ethical requirements.
Read More
Exclusion Criteria
  • NO
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
experimental groupNO.-
Primary Outcome Measures
NameTimeMethod
AEFrom the prescription of Feilike HeJi to 3 days after stop using Feilike HeJi.

All the data to be collected are included in Table A and Table B of the registration And Research Information collection of Adults using Feilike HeJi.Data in Table A are filled in by authorized researchers (such as clinicians) and patients, and data in Table B are filled in by authorized researchers (such as clinicians).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (25)

Peking University Third Hospital Yanqing Hospital

🇨🇳

Beijing, Beijing, China

The Eighth Affiliated Hospital, Sun Yat-sen University

🇨🇳

Shenzhen, Guangdong, China

Henan Provincial People's Hospital

🇨🇳

Zhengzhou, Henan, China

Nanjing Jiangning Hospital of traditional Chinese Medicine

🇨🇳

Nankín, Jiangsu, China

Jiangxi University of Traditional Chinese Medicine Affiliated Hospital

🇨🇳

Nanchang, Jiangxi, China

Wanzai County People's Hospital, Jiangxi Province

🇨🇳

Yichun, Jiangxi, China

First People's Hospital of Jining City

🇨🇳

Jining, Shandong, China

Peking University Binhai Hospital

🇨🇳

Tianjin, Tianjin, China

Tianjin First Central Hospital

🇨🇳

Tianjin, Tianjin, China

First Affiliated Hospital of Xi'an Medical College

🇨🇳

Xian, Shanxi, China

People's Hospital of Ningxiang

🇨🇳

Changsha, Hunan, China

Changchun Second Hospital

🇨🇳

Changchun, Jilin, China

Guizhou Provincial People's Hospital

🇨🇳

Guiyang, Guizhou, China

Yifu Hospital Affiliated to Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

China-Japan Friendship Hospital

🇨🇳

Beijing, Beijing, China

Southern University of Science and Technology Hospital

🇨🇳

Shenzhen, Guangdong, China

The First Affiliated Hospital Of Guangzhou Medical University

🇨🇳

Guangzhou, Guangdong, China

The Second People's Hospital of Guiyang

🇨🇳

Guiyang, Guizhou, China

Guixi People's Hospital, Jiangxi Province

🇨🇳

Guixi, Jiangxi, China

Hanyin County People's Hospital, Shaanxi Province

🇨🇳

Ankang, Shanxi, China

First Affiliated Hospital, Hunan University of Traditional Chinese Medicine

🇨🇳

Changsha, Hunan, China

Nanjing Central Hospital

🇨🇳

Nanjing, Jiangsu, China

Xiangtan County People's Hospital

🇨🇳

Changsha, Hunan, China

People's Hospital of Fuxin Mongolian Autonomous County

🇨🇳

Fuxin, Liaoning, China

People's Hospital of Mengyin County

🇨🇳

Linyi, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath